Modified DRPT better for detecting primary angle closure

Article

Conducting a modified dark room provocative test (DRPT) is better for the diagnosis of primary angle closure, compared to gonioscopic angle assessment.

Conducting a modified dark room provocative test (DRPT) is better for the diagnosis of primary angle closure, compared to gonioscopic angle assessment, reveals a study in the Journal of Glaucoma.

Dr Dejiao Li led a cross-sectional observational prospective clinical study on 76 eyes of 76 patients. The anterior chamber angle configuration was measured in a light room and then after three minutes of dark adaptation using anterior segment optical coherence tomography (AS-OCT).

In light room conditions at baseline and after 1.5 hours of dark adaptation gonioscopy and Perkin's applanation tonometry were performed. The DRPT was identified as positive if intraocular pressure (IOP) increased by ≥8 mmHg after 1.5 hours of dark adaptation.

There were a significant number of eyes with an increased number of closed angle quadrants for the OCT examination at 3 minutes of dark adaptation, compared to gonioscopy at 1.5 hours of dark adaptation. For AS-OCT the area under the receiver operator characteristics curve was significantly larger, compared to gonioscopy.

A modified DRPT in combination with an anterior chamber angle assessment by OCT at 3 minutes of dark adaptation demonstrated a higher diagnostic precision for primary angle closure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.